Document Detail


Ulipristal acetate: the newest emergency contraceptive.
MedLine Citation:
PMID:  22900810     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
More than 50 percent of pregnancies in the United States are unplanned. Emergency contraception has been shown to possibly reduce the risk of pregnancy by as much as 75 percent. Ulipristal acetate is a selective progesterone receptor modulator that was approved by the U.S. Food and Drug Administration (FDA) for emergency contraceptive use in August 2010. This article reviews information on its mechanism of action, efficacy, safety and implications for women's health nurses.
Authors:
Jeanne M Wilton
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nursing for women's health     Volume:  16     ISSN:  1751-486X     ISO Abbreviation:  Nurs Womens Health     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101304602     Medline TA:  Nurs Womens Health     Country:  United States    
Other Details:
Languages:  eng     Pagination:  331-5     Citation Subset:  N    
Copyright Information:
© 2012 AWHONN.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical research nursing: evidence today, better practices tomorrow.
Next Document:  Continence promotion: how nurses can educate women.